The Gap, Australia

Michael Francis Good

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 26(Granted Patents)


Location History:

  • Queensland, AU (2017 - 2019)
  • Nathan, AU (2019 - 2022)
  • The Gap, AU (2001 - 2023)

Company Filing History:


Years Active: 2001-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Michael Francis Good: Innovator in Immunogenic Peptides

Introduction

Michael Francis Good is a prominent inventor based in The Gap, Australia. He has made significant contributions to the field of immunology, particularly through his innovative work on immunogenic peptides. With a total of seven patents to his name, Good's research focuses on enhancing immune responses to group A streptococcal bacteria.

Latest Patents

Among his latest patents is an immunogenic peptide against group A. This modified p145 peptide is designed to have enhanced mucosal immunogenicity, which is crucial for eliciting a mucosal immune response in mammals, including humans. The intramuscular administration of this modified p145 peptide is noted to be particularly efficacious. Additionally, an S2 peptide or variant may be co-administered with the modified p145 peptide to further enhance the immune response.

Career Highlights

Michael Francis Good has had a notable career, working at Griffith University, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of immune responses and developing new therapeutic strategies.

Collaborations

Good has collaborated with several professionals in his field, including Manisha Pandey and Michael Raymond Batzloff. These collaborations have enriched his research and contributed to the success of his innovative projects.

Conclusion

Michael Francis Good is a distinguished inventor whose work on immunogenic peptides has the potential to significantly impact public health. His dedication to advancing immunology through innovative research is commendable.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…